scholarly journals Impact of policy changes on the provision of naloxone by pharmacies in Ontario, Canada: a population‐based time–series analysis

Addiction ◽  
2021 ◽  
Author(s):  
Tony Antoniou ◽  
Diana Martins ◽  
Tonya Campbell ◽  
Mina Tadrous ◽  
Charlotte Munro ◽  
...  
2014 ◽  
Vol 192 (5) ◽  
pp. 1450-1456 ◽  
Author(s):  
Michael Ordon ◽  
David Urbach ◽  
Muhammad Mamdani ◽  
Refik Saskin ◽  
R. John D’A Honey ◽  
...  

1995 ◽  
Vol 222 (3) ◽  
pp. 311-326 ◽  
Author(s):  
Robert Rutledge ◽  
John P. Hunt ◽  
Christopher W. Lentz ◽  
Samir M. Fakhry ◽  
Anthony A. Meyer ◽  
...  

Author(s):  
Ippazio Cosimo Antonazzo ◽  
Carla Fornari ◽  
Sandy Maumus-Robert ◽  
Eleonora Cei ◽  
Olga Paoletti ◽  
...  

Background: In 2020, during the COVID-19 pandemic, Italy implemented two national lockdowns aimed at reducing virus transmission. We assessed whether these lockdowns affected anti-seizure medication (ASM) use and epilepsy-related access to emergency departments (ED) in the general population. Methods: We performed a population-based study using the healthcare administrative database of Tuscany. We defined the weekly time series of prevalence and incidence of ASM, along with the incidence of epilepsy-related ED access from 1 January 2018 to 27 December 2020 in the general population. An interrupted time-series analysis was used to assess the effect of lockdowns on the observed outcomes. Results: Compared to pre-lockdown, we observed a relevant reduction of ASM incidence (0.65; 95% Confidence Intervals: 0.59–0.72) and ED access (0.72; 0.64–0.82), and a slight decrease of ASM prevalence (0.95; 0.94–0.96). During the post-lockdown the ASM incidence reported higher values compared to pre-lockdown, whereas ASM prevalence and ED access remained lower. Results also indicate a lower impact of the second lockdown for both ASM prevalence (0.97; 0.96–0.98) and incidence (0.89; 0.80–0.99). Conclusion: The lockdowns implemented during the COVID-19 outbreaks significantly affected ASM use and epilepsy-related ED access. The potential consequences of these phenomenon are still unknown, although an increased incidence of epilepsy-related symptoms after the first lockdown has been observed. These findings emphasize the need of ensuring continuous care of epileptic patients in stressful conditions such as the COVID-19 pandemic.


2017 ◽  
Vol 108 (5-6) ◽  
pp. e462-e467 ◽  
Author(s):  
Naveen Poonai ◽  
Shruti Mehrotra ◽  
Muhammad Mamdani ◽  
Anastasia Patmanidis ◽  
Michael Miller ◽  
...  

2019 ◽  
Vol 191 (4) ◽  
pp. E93-E99 ◽  
Author(s):  
Matthew A. Weir ◽  
Justin Slater ◽  
Racquel Jandoc ◽  
Sharon Koivu ◽  
Amit X. Garg ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document